2026 -- S 2385 | |
======== | |
LC004629 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2026 | |
____________ | |
A N A C T | |
RELATING TO HUMAN SERVICES -- MEDICAL ASSISTANCE -- PRESCRIPTION | |
DRUGS | |
| |
Introduced By: Senators Bissaillon, Murray, LaMountain, and DiMario | |
Date Introduced: January 30, 2026 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Chapter 40-21 of the General Laws entitled "Medical Assistance — |
2 | Prescription Drugs" is hereby amended by adding thereto the following section: |
3 | 40-21-4. Prohibition of prior authorization or step therapy protocol. |
4 | (a) The Rhode Island medical assistance program, as defined under chapter 8 of this title, |
5 | and any contract between the Rhode Island medical assistance program and a managed care |
6 | organization shall not require prior authorization or a step therapy protocol for the coverage of a |
7 | medication classified as an anticonvulsant or antipsychotic on their drug formulary. |
8 | (b) If the secretary of the executive office of health and human services determines that |
9 | authorization from a federal agency is necessary for the implementation of this section, the |
10 | secretary is authorized to seek such state plan amendment and may delay implementing the |
11 | provisions until the authorization is granted. |
12 | (c) The Rhode Island medical assistance program shall require, through amending current |
13 | and future medical assistance managed care contracts, that the managed care organizations meet |
14 | the provisions of this section. |
15 | (d) The provisions of subsection (a) of this section do not affect clinical prior authorization |
16 | edits to prescriptions of medications classified as an anticonvulsant or antipsychotic. |
17 | (e) This section does not prevent the Rhode Island medical assistance program and any |
18 | contract between the Rhode Island medical assistance program and a managed care organization |
| |
1 | from denying a medication that has been removed from the market due to safety concerns from the |
2 | federal Food and Drug Administration. |
3 | (f) For the purposes of this section, "step therapy protocol" means a protocol that |
4 | establishes a specific sequence in which prescription medications for a specified medical condition |
5 | are medically necessary for a particular enrollee and are covered under a pharmacy or medical |
6 | benefit by the Rhode Island medical assistance program or a managed care organization, including |
7 | self-administered and physician-administered drugs. |
8 | (g) On or before July 1, 2029, the Rhode Island medical assistance program and any |
9 | managed care organization that has a contract with the Rhode Island medical assistance program |
10 | shall collect and provide to the executive office of health and human services, in a form and |
11 | frequency acceptable to the secretary, a report that includes the following data for the years 2021- |
12 | 2029: |
13 | (1) For anticonvulsants and antipsychotics; |
14 | (i) The annual gross amount spent; |
15 | (ii) The annual net amount spent after rebates; |
16 | (iv) The average annual cost by class for generic and non-generic anticonvulsant and |
17 | antipsychotic medications; |
18 | (v) The total number of anticonvulsant and antipsychotic medication claims; |
19 | (vi) The percentage of adherence to the preferred drug list ("PDL") for anticonvulsant and |
20 | antipsychotic medications; |
21 | (vii) The total number of prior authorizations submitted for nonpreferred anticonvulsant |
22 | and antipsychotic medications; |
23 | (viii) The total number of step therapy exceptions requested for nonpreferred |
24 | anticonvulsant and antipsychotic medications; |
25 | (ix) The total number of step edits per nonpreferred anticonvulsant and antipsychotic |
26 | medication; |
27 | (x) The percentages of prior authorization and step therapy approvals and denials; and |
28 | (xi) The generic anticonvulsant and generic antipsychotic medication utilization |
29 | percentages. |
30 | (h) On or before July 1, 2029, the director of the department of health shall collect and |
31 | provide to the executive office of health and human services, in a form and frequency acceptable |
32 | to the secretary, a report that includes the following data for the years 2021-2029 from the state and |
33 | from each of the thirty-nine (39) municipalities: |
34 | (1) Gross amount, non-aggregated by entity type, spent on services and personnel related |
| LC004629 - Page 2 of 4 |
1 | to mental health emergencies performed by the following entities: |
2 | (i) Ground ambulance transport; |
3 | (ii) Air ambulance transport; |
4 | (iii) Hospitals, including inpatient and emergency departments; |
5 | (iv) Police departments; and |
6 | (v) Fire departments. |
7 | (i) On or before October 1, 2029, the executive office of health and human services shall |
8 | produce and provide the information collected pursuant to subsections (g) and (h) of this section to |
9 | the speaker of the house of representatives, the president of the senate, the house of representatives |
10 | committee on finance, and the senate committee on health and human services. |
11 | (j) The provisions of this section shall sunset and be repealed effective December 31, 2029. |
12 | (k) This section applies to all policies, contracts, and plans executed, delivered, issued for |
13 | delivery, continued or renewed in this state on or after January 1, 2027. This section shall sunset |
14 | and be repealed on December 31, 2029. |
15 | SECTION 2. This act shall take effect on January 1, 2027, and shall sunset and be repealed |
16 | on December 31, 2029. |
======== | |
LC004629 | |
======== | |
| LC004629 - Page 3 of 4 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HUMAN SERVICES -- MEDICAL ASSISTANCE -- PRESCRIPTION | |
DRUGS | |
*** | |
1 | This act would prohibit the Rhode Island medical assistance program, and any contract |
2 | between the Rhode Island medical assistance program and a managed care organization, from |
3 | requiring prior authorization or a step therapy protocol for the coverage of a medication classified |
4 | as an anticonvulsant or antipsychotic. |
5 | This act would take effect on January 1, 2027, and would sunset and be repealed on |
6 | December 31, 2029. |
======== | |
LC004629 | |
======== | |
| LC004629 - Page 4 of 4 |